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of complete differentiation in cardiac phenotype during these few
days.
Conclusions: In this study the addition of retinoic acid during
serum reduction favours a cardiac phenotype at the expense of
skeletal muscle trans-differentiation, confirmed by NP and ET system
expression. Moreover, the lacking of a complete differentiation of
cells on CNT-Sc highlights the need of more day of culture to realize
this process. Nevertheless further analysis on novel biomaterials
to enhance cell growth/proliferation and to support the damaged
heart will be needed to bring heart tissue engineering into clinical
application, these results are a useful starting point to develop new
Sc-based biomaterials.
doi:10.1016/j.vph.2015.11.014
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Objectives: Endogenous estrogens are important regulators of
cardiovascular homeostasis in premenopausal women and interfere
with the development of hypertension and coronary artery disease.
Estrogensmediate profound effects throughout the body, and regulate
physiological and pathological processes in both woman and men.
These hormones act via three different estrogen receptors (ERs),
ERα and ERβ, and GPER. GPER is implicated in both rapid signaling
and transcriptional regulation and is expressed in the cardiovascular
system. Ischemic and pharmacological pre-conditioning are thera-
peutic interventions that limit reperfusion injury via RISK pathway.
However, these cardioprotective interventions are blunted in patho-
logical animal models. Whether GPER plays a role in preconditioning
cardioprotection has not been fully investigated yet. The aim of this
study was to evaluate the potential cardioprotective role mediated
by GPER and ERs in spontaneously hypertensive female rats in a
preconditioning context.
Materials and methods: The effects of the selective GPR30
agonist, G1, or of the selective GPR30 antagonist, G15, both given
20 min after ischemia, were evaluated on ischemia/reperfusion (I/R)
injury. Specific inhibitors of the RISK pathway (AkT, L-NIO and
MitoKATP channels) were co-infused with G1, just before I/R. For
comparative purposes, the same protocol was used to study the role of
the ER antagonist, ICI. Infarct size and cardiac function were assessed
by using the isolated and Langendorff perfused heart technique.
Results: Pre-treatment with G1 limited I/R injury at the lowest
concentration tested (10 nM), while the cardioprotective effect was
blunted at higher doses (100 nM). Administration of G15 (100 nM)
induced an increase of myocardial damage which was greater than
that induced by ICI (100 nM). Co-infusionwith specific RISK inhibitors
blocked the G1 protective effects.
Conclusions: These results suggest that GPERs play a major role
in mediating cardioprotection in preconditioning. Our data pave the
way to evaluate whether, in female, G1 can be regarded as a potential
therapeutic agent in the presence of hypertension, being able to
target and attenuate reperfusion-induced cell death and to overcome
hypertension-induced heart failure.
doi:10.1016/j.vph.2015.11.015
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Objectives: Recently, we have demonstrated that resident tissue-
specific c-kit + endogenous cardiac stem cells (eCSCs) are essential
agents for myocyte replenishment in adult rodents. However, the
first mouse model for c-kit genetic fate mapping using a Cre knock-in
the ckit Exon1 concluded that the c-kitpos cells minimally produce
cardiomyocytes (CMs) either during development as well as in
healthy or damaged adult hearts. PURPOSE: We addressed whether a
tamoxifen (TAM)-inducible Cre knock-in the c-kit Exon1 efficiently
recombine c-kit + eCSCs in the adult myocardium for reliable cell
fate mapping.
Materials and methods: Heterozygous c-kitCreER(T2)/+ mice
were crossed with the global double-fluorescent Cre reporter mice
(R26mT/mG) that express in the ROSA (R26) locus amembrane-targeted
tandem Tomato dimer (mT) prior to Cre excision and membrane-
targeted green fluorescent protein (mG or GFP) after Cre recombination.
Results: CreER(T2) Knock-in in the c-kit Exon 1 produces a null
c-kit allele with mice that are hemizygous c-kit hypomorphs. Indeed,
c-kitCreER(T2) knock-in downregulates c-kit expression in all c-kit
expressing cells of the body. When double mutant c-kitCreER(T2)/+:
R26mT-mG/+ mice were treated with standard TAM diet for
3 months, ~80% of total c-kitpos bone marrow cells were recombined
to express eGFP. The same high level of recombination was shown
in c-kit + cells of the skin, spleen, lung and testis. When we isolated
c-kit + HSCs, only a fraction of them, about 15%, were recombined
by TAM. Thus, the c-kitCreER(T2)/+ mouse, exactly like the recently
reported c-kitmER-CremER/+ mouse, correctly labels the known
c-kit expressing cells even though at an expected different rate
proportional to c-kit expression. Importantly, TAM labeled ~80% of
all c-kit + cardiac cells. However, these recombined c-kit + cardiac
cells were all lineage-committed cells as they were all either CD45+
or CD31 + cells. When gating the low expressing c-kit (c-kit-low)
CD45neg/CD31neg cells, that are enriched for true eCSCs, only ~8% of
them were recombined to express GFP. Consequently, only rare
GFP+ CMs were detected. Finally, the c-kitCreER(T2)/+ null allele
reduced clonogenicity and sphere formation of eCSCs when com-
pared to WT c-kit+/+ counterpart.
Conclusions: Cre recombination in c-kitCreER(T2)/+ mice is
dependent on c-kit expression. Cells that express high levels of c-kit
are efficiently recombined. However, true c-kit-low eCSCs are only
minimally recombined. Thus, using this fate map strategy, it impossible
to appropriately quantify the cardiac cell progeny, and CMs in particular,
of c-kitlow eCSCs in vivo.
doi:10.1016/j.vph.2015.11.016
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